WIRE — Novo Nordisk pasarkan zat aktif semaglutide via 2 produk dengan indikasi berbeda, yaitu Ozempic untuk terapi diabetes melitus tipe 2 Wegovy untuk manajemen berat badan.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.